236 related articles for article (PubMed ID: 19338032)
1. Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice.
Shen X; Wan C; Ramaswamy G; Mavalli M; Wang Y; Duvall CL; Deng LF; Guldberg RE; Eberhart A; Clemens TL; Gilbert SR
J Orthop Res; 2009 Oct; 27(10):1298-305. PubMed ID: 19338032
[TBL] [Abstract][Full Text] [Related]
2. Prolyl hydroxylase inhibitors increase the production of vascular endothelial growth factor by periodontal fibroblasts.
Agis H; Watzek G; Gruber R
J Periodontal Res; 2012 Apr; 47(2):165-73. PubMed ID: 21954882
[TBL] [Abstract][Full Text] [Related]
3. Prolyl hydroxylase inhibitors increase the production of vascular endothelial growth factor in dental pulp-derived cells.
Müller HD; Cvikl B; Gruber R; Watzek G; Agis H
J Endod; 2012 Nov; 38(11):1498-503. PubMed ID: 23063224
[TBL] [Abstract][Full Text] [Related]
4. Activation of hypoxia-inducible factors in hyperoxia through prolyl 4-hydroxylase blockade in cells and explants of primate lung.
Asikainen TM; Schneider BK; Waleh NS; Clyman RI; Ho WB; Flippin LA; Günzler V; White CW
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10212-7. PubMed ID: 16009933
[TBL] [Abstract][Full Text] [Related]
5. Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells.
Chung LC; Tsui KH; Feng TH; Lee SL; Chang PL; Juang HH
Mol Nutr Food Res; 2011 Nov; 55(11):1666-76. PubMed ID: 21936051
[TBL] [Abstract][Full Text] [Related]
6. Systemic preconditioning by a prolyl hydroxylase inhibitor promotes prevention of skin flap necrosis via HIF-1-induced bone marrow-derived cells.
Takaku M; Tomita S; Kurobe H; Kihira Y; Morimoto A; Higashida M; Ikeda Y; Ushiyama A; Hashimoto I; Nakanishi H; Tamaki T
PLoS One; 2012; 7(8):e42964. PubMed ID: 22880134
[TBL] [Abstract][Full Text] [Related]
7. Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors.
Warnecke C; Griethe W; Weidemann A; Jürgensen JS; Willam C; Bachmann S; Ivashchenko Y; Wagner I; Frei U; Wiesener M; Eckardt KU
FASEB J; 2003 Jun; 17(9):1186-8. PubMed ID: 12709400
[TBL] [Abstract][Full Text] [Related]
8. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Knowles HJ; Tian YM; Mole DR; Harris AL
Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
[TBL] [Abstract][Full Text] [Related]
10. Prolyl hydroxylase inhibitors protect from the bone loss in ovariectomy rats by increasing bone vascularity.
Liu X; Tu Y; Zhang L; Qi J; Ma T; Deng L
Cell Biochem Biophys; 2014 May; 69(1):141-9. PubMed ID: 24242187
[TBL] [Abstract][Full Text] [Related]
11. Effect of chemical stabilizers of hypoxia-inducible factors on early lung development.
Groenman FA; Rutter M; Wang J; Caniggia I; Tibboel D; Post M
Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L557-67. PubMed ID: 17545484
[TBL] [Abstract][Full Text] [Related]
12. Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair.
Ghadge SK; Messner M; Van Pham T; Doppelhammer M; Petry A; Görlach A; Husse B; Franz WM; Zaruba MM
J Mol Med (Berl); 2017 Aug; 95(8):825-837. PubMed ID: 28550361
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice.
Milkiewicz M; Pugh CW; Egginton S
J Physiol; 2004 Oct; 560(Pt 1):21-6. PubMed ID: 15319416
[TBL] [Abstract][Full Text] [Related]
14. The role of HIF in cobalt-induced ischemic tolerance.
Jones SM; Novak AE; Elliott JP
Neuroscience; 2013 Nov; 252():420-30. PubMed ID: 23916558
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of HIF-1alpha, HIF-2alpha, and VEGF by prolyl 4-hydroxylase inhibition in human lung endothelial and epithelial cells.
Asikainen TM; Ahmad A; Schneider BK; Ho WB; Arend M; Brenner M; Günzler V; White CW
Free Radic Biol Med; 2005 Apr; 38(8):1002-13. PubMed ID: 15780758
[TBL] [Abstract][Full Text] [Related]
16. Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy in the rat 50/10 model.
Trichonas G; Lee TJ; Hoppe G; Au J; Sears JE
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4919-26. PubMed ID: 23761085
[TBL] [Abstract][Full Text] [Related]
17. Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL/6J mice through enhanced angiogenesis and osteogenesis.
Peng J; Lai ZG; Fang ZL; Xing S; Hui K; Hao C; Jin Q; Qi Z; Shen WJ; Dong QN; Bing ZH; Fu DL
PLoS One; 2014; 9(11):e112744. PubMed ID: 25394221
[TBL] [Abstract][Full Text] [Related]
18. Transient hypoxia-inducible factor activation in rat renal ablation and reduced fibrosis with L-mimosine.
Yu X; Fang Y; Ding X; Liu H; Zhu J; Zou J; Xu X; Zhong Y
Nephrology (Carlton); 2012 Jan; 17(1):58-67. PubMed ID: 21777345
[TBL] [Abstract][Full Text] [Related]
19. Prolyl-hydroxylase inhibition preserves endothelial cell function in a rat model of vascular ischemia reperfusion injury.
Barnucz E; Veres G; Hegedűs P; Klein S; Zöller R; Radovits T; Korkmaz S; Horkay F; Merkely B; Karck M; Szabó G
J Pharmacol Exp Ther; 2013 Apr; 345(1):25-31. PubMed ID: 23388095
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin affects early fracture healing in mice.
Holstein JH; Klein M; Garcia P; Histing T; Culemann U; Pizanis A; Laschke MW; Scheuer C; Meier C; Schorr H; Pohlemann T; Menger MD
Br J Pharmacol; 2008 Jul; 154(5):1055-62. PubMed ID: 18454167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
